342 filings
Page 7 of 18
8-K
hcn88
24 Oct 08
Regulation FD Disclosure
12:00am
8-K
dxfk 7d1n
16 Oct 08
Other Events
12:00am
8-K
kkqvnhm
10 Oct 08
Inspire Initiates Phase 1 Trial of INS117548 for Glaucoma
12:00am
8-K
qka744h8447 u65ickgz
30 Sep 08
Other Events
12:00am
8-K
ho9k7q6qw 4pgmdz
23 Sep 08
Termination of a Material Definitive Agreement
12:00am
8-K
fx0yebwdae vq
15 Sep 08
Inspire Announces Plans for Clinical Testing of New Compound
12:00am
8-K
u2dr69ua dw
2 Sep 08
Other Events
12:00am
8-K
rfapnel
11 Aug 08
Results of Operations and Financial Condition
12:00am
8-K
m3p364xctu94oz s71
1 Aug 08
Inspire Provides Update on Cystic Fibrosis Clinical Program
12:00am
8-K
crd4t3a
27 Jun 08
Departure of Directors or Principal Officers
12:00am
8-K
jfk0thtvlbctoln6
9 Jun 08
Inspire Announces Achievement of Primary Endpoint In Phase 3
12:00am
8-K
b785o1cnu pg7zxqkx
8 May 08
Results of Operations and Financial Condition
12:00am
8-K
i0lwx4rj056xl9ihb
25 Apr 08
Inspire to Discontinue Development of Epinastine Nasal Spray
12:00am
DEFA14A
krlo5 4ubz5
25 Apr 08
Additional proxy soliciting materials
12:00am
8-K
1hmg6u og
26 Mar 08
Departure of Directors or Principal Officers
12:00am
8-K
m6f29cx93j9hkde02
10 Mar 08
Departure of Directors or Principal Officers
12:00am